참고문헌 (115)

1. Abernathy CO, Thomas DJ and Calderon RL. Health effects and risk assessment of arsenic. J Nutr 2003; 133: 1536S-1538S 

   상세보기

2. Ahmad SA, Sayed MH, Barua S, Khan MH, Faruquee MH, Jalil A, Hadi SA and Talukder HK. Arsenic in drinking water and pregnancy outcomes. Environ Health Perspect 2001; 109: 629-631？？？？ 

   상세보기

3. Aposhian HV. Enzymatic methylation of arsenic species and other new approaches to arsenic toxicity. Annu Rev Pharmacol Toxicol 1997; 37: 397-419 

   상세보기

4. Aposhian HV, Gurzau ES, Le XC, Gurzau A, Healy SM, Lu X, Ma M, Yip L, Zakharyan RA, Maiorino RM, Dart RC, Tircus MG, Gonzalez-Ramirez D, Morgan DL, Avram D and Aposhian MM. Occurrence of monomethylarsonous acid in urine of humans exposed to inorganic arsenic. Chem Res Toxicol 2000a; 13: 693-697 

   상세보기

5. Aposhian HV, Zheng B, Aposhian MM, Le XC, Cebrian ME, Cullen W, Zakharyan RA, Ma M, Dart RC, Cheng Z, Andrewes P, Yip L, O'Malley GF, Maiorino RM, Van Voorhies W, Healy SM and Titcomb A. DMPSarsenic challenge test. II. Modulation of arsenic species, including monomethylarsonous acid (MMA (III)), excreted in human urine. Toxicol Appl Pharmacol 2000b; 165: 74-83 

   상세보기

6. Barchowsky A, Dudek EJ, Treadwell MD and Wetterhahn KE. Arsenic induces oxidant stress and NF-kappa B activation in cultured aortic endothelial cells. Free Radic Biol Med 1996; 21: 783-790 

   상세보기

7. Bates MN, Smith AH and Cantor KP. Case-control study of bladder cancer and arsenic in drinking water. Am J Epidemiol 1995; 141: 523-530 

   상세보기

8. Bates MN, Smith AH and Hopenhayn-Rich C. Arsenic ingestion and internal cancers: a review. Am J Epidemiol 1992; 135: 462-476 

   상세보기

9. Berg M, Tran HC, Nguyen TC, Pham HV, Schertenleib R and Giger W. Arsenic contamination of groundwater and drinking water in Vietnam: a human health threat. Environ Sci Technol 2001; 35: 2621-26261 

   상세보기

10. Bhattacharyya R, Chatterjee D, Nath B, Jana J, Jacks G and Vahter M. High arsenic groundwater: mobilization, metabolism and mitigation--an overview in the Bengal Delta Plain. Mol Cell Biochem 2003; 253: 347-355 

    상세보기

11. Buchet JP, Lauwerys R and Roels H. Comparison of the urinary excretion of arsenic metabolites after a single oral dose of sodium arsenite, monomethylarsonate, or dimethylarsinate in man. Int Arch Occup Environ Health 1981; 48: 71-79 

    상세보기

12. Buchet JP, Pauwels J and Lauwerys R. Assessment of exposure to inorganic arsenic following ingestion of marine organisms by volunteers. Environ Res 1994; 66: 44-51d, 

    상세보기

13. Bunderson M, Coffin JD and Beall HD. Arsenic induces peroxynitrite generation and cyclooxygenase-2 protein expression in aortic endothelial cells: possible role in atherosclerosis. Toxicol Appl Pharmacol 2002; 184: 11-18 

    상세보기

14. Caceres DD, Pino P, Montesinos N, Atalah E, Amigo H andp Loomis D. Exposure to inorganic arsenic in drinking water and total urinary arsenic concentration in a Chilean population. Environ Res 2005; 98: 151-159 

    상세보기

15. Cebrian ME, Albores A, Aguilar M and Blakely E. Chronic arsenic poisoning in the north of Mexico. Hum Toxicol 2, 1983; 121-133 

    상세보기

16. Chen CJ, Chiou HY, Chiang MH, Lin LJ and Tai TY. Doseresponse relationship between ischemic heart disease mortality and long-term arsenic exposure. Arterioscler Thromb Vasc Biol 1996; 16: 504-5101 

    상세보기

17. Chen J and Lopez JA. Interactions of platelets with subendothelium and endothelium. Microcirculation 12, 2005; 235-246 

    상세보기

18. Chiou HY, Chiou ST, Hsu YH, Chou YL, Tseng CH, Wei ML and Chen CJ. Incidence of transitional cell carcinoma and arsenic in drinking water: a follow-up study of 8,102 residents in an arseniasis-endemic area in northeastern Taiwan. Am J Epidemiol 2001; 153: 411-418 

    상세보기

19. Chiou HY, Huang WI, Su CL, Chang SF, Hsu YH and Chen CJ. Dose-response relationship between prevalence of cerebrovascular disease and ingested inorganic arsenic. Stroke 1997; 28: 1717-1723 

    상세보기

20. Chou WC and Dang CV. Acute promyelocytic leukemia: recent advances in therapy and molecular basis of response to arsenic therapies. Curr Opin Hematol 2005; 12: 1- 6 

    상세보기

21. Chouchane S and Snow ET. In vitro effect of arsenical compounds on glutathione-related enzymes. Chem Res Toxicol 2001; 14: 517-522 

    상세보기

22. Christen K. Chickens, manure, and arsenic. Environ Sci Technol 2001; 35: 184A-185A 

    상세보기

23. Concha G, Vogler G, Lezcano D, Nermell B and Vahter M. Exposure to inorganic arsenic metabolites during early human development. Toxicol Sci 1998; 44: 185-190 

    상세보기

24. Cullen WR, McBride BC and Reglinski J. The reaction of methylarsenicals with thiols: Some biological implications. J Inorg Biochem 1984; 21: 179-194 

    상세보기

25. Cuzick J, Sasieni P and Evans S. Ingested arsenic, keratoses, and bladder cancer. Am J Epidemiol 1992; 136: 417-421 

    상세보기

26. De Peyster A and Silvers JA. Arsenic levels in hair of workers in a semiconductor fabrication facility. Am Ind Hyg Assoc J 2005; 56: 377-383 

27. Del Razo LM, Quintanilla-Vega B, Brambila-Colombres E, Calderon-Aranda ES, Manno M and Albores A. Stress proteins induced by arsenic. Toxicol Appl Pharmacol 2001a; 177: 132-148 

    상세보기

28. Del Razo LM, Styblo M, Cullen WR and Thomas DJ. Determination of trivalent methylated arsenicals in biological matrices. Toxicol Appl Pharmacol 2001b; 174: 282-293 

    상세보기

29. Edmonds JS, Shibata Y, Francesconi KA, Rippingale RJ and Moritaet M. Arsenic transformations in short marine food chains studied by HPLC-ICP MS. Appl Organomet Chem 1997; 11: 281-287 

    상세보기

30. Eguchi N, Kuroda K and Endo G. Metabolites of arsenic induced tetraploids and mitotic arrest in cultured cells. Arch Environ Contam Toxicol 1997; 32: 141-145 

    상세보기

31. Gebel TW. Arsenic and drinking water contamination. Science 1999; 283: 1458-1459 

    상세보기

32. Gregus Z and Nemeti B. Purine nucleoside phosphorylase as a cytosolic arsenate reductase. Toxicol Sci 2002; 70: 13-19 

    상세보기

33. Guo X, Fujino Y, Kaneko S, Wu K, Xia Y and Yoshimura T. Arsenic contamination of groundwater and prevalence of arsenical dermatosis in the Hetao plain area, Inner Mongolia, China. Mol Cell Biochem 2001; 222: 137-140 

    상세보기

34. Hasegawa H, Sohrin Y, Matsui M, Hojo M, Kawashima M. Speciation of arsenic in natural waters by solvent extraction and hydride generation atomic absorption spectrometry. Anal Chem 1994; 66: 3247-3252 

    상세보기

35. Heydorn K. Environmental variation of arsenic levels in human blood determines by neutron activation analysis. Clin Chim Acta 1997; 28: 349-357 

    상세보기

36. Hirano S, Cui X, Li S, Kanno S, Kobayashi Y, Hayakawa T and Shraim A. Difference in uptake and toxicity of trivalent and pentavalent inorganic arsenic in rat heart microvessel endothelial cells. Arch Toxicol 2003; 77: 305-312？？ 

    상세보기

37. Hirano S, Kobayashi Y, Cui X, Kanno S, Hayakawa T and Shraim A. The accumulation and toxicity of methylated arsenicals in endothelial cells: important roles of thiol compounds. Toxicol Appl Pharmacol 2004; 198: 458-467 

    상세보기

38. Hopenhayn-Rich C, Biggs ML, Fuchs A, Bergoglio R, Tello EE, Nicolli H and Smith AH. Bladder cancer mortality associated with arsenic in drinking water in Argentina. Epidemiology 1996; 7: 117-124 

    상세보기

39. Huang C, Ke Q, Costa M and Shi X. Molecular mechanisms of arsen1ic carcinogenesis. Mol Cell Biochem 2004; 255: 57-66 

    상세보기

40. Kitchin KT and Ahmad S. Oxidative stress as a possible mode of action for arsenic carcinogenesis. Toxicol Lett 2003; 137: 3-13 

    상세보기

41. Kligerman AD, Doerr CL, Tennant AH, Harrington-Brock K, Allen JW, Winkfield E, Poorman-Allen P, Kundu B, Funasaka K, Roop BC, Mass MJ and DeMarini DM. Methylated trivalent arsenicals as candidate ultimate genotoxic forms of arsenic: induction of chromosomal mutations but not gene mutations. Environ Mol Mutagen 2003; 42: 192-205？？？ 

    상세보기

42. Kohler M, Hofmann K, Volsgen F, Thurow K and Koch A. Bacterial release of arsenic ions and organoarsenic compounds from soil contaminated by chemical warfare agents. Chemosphere 2001; 42: 425-4291 

    상세보기

43. Lai MS, Hsueh YM, Chen CJ, Shyu MP, Chen SY, Kuo TL, Wu MM and Tai TY. Ingested inorganic arsenic and prevalence of diabetes mellitus. Am J Epidemiol 1994; 139: 484-492 

    상세보기

44. Lamm SH, Engel A, Kruse MB, Feinleib M, Byrd DM, Lai S and Wilson R. Arsenic in drinking water and bladder cancer mortality in the United States: an analysis based on 133 U.S. counties and 30 years of observation. J Occup Environ Med 2004; 46: 298-306 

    상세보기

45. Le XC, Lu X, Ma M, Cullen WR, Aposhian HV and Zheng B. Speciation of key arsenic metabolic intermediates in human urine. Anal Chem 2000a; 72: 5172-5177 

    상세보기

46. Le XC, Ma M, Cullen WR, Aposhian HV, Lu X and Zheng B. Determination of monomethylarsonous acid, a key arsenic methylation intermediate, in human urine. Environ Health Perspect 2000b; 108: 1015-1018 

    상세보기

47. Lee MY, Bae ON, Chung SM, Kang KT, Lee JY and Chung JH. Enhancement of platelet aggregation and thrombus formation by arsenic in drinking water: a contributing factor to cardiovascular disease. Toxicol Appl Pharmacol 2002; 179: 83-88 

    상세보기

48. Lee MY, Jung BI, Chung SM, Bae ON, Lee JY, Park JD, Yang JS, Lee H and Chung JH. Arsenic-induced dysfunction in relaxation of blood vessels. Environ Health Perspect 2003; 111: 513-7 

    상세보기

49. Lee MY, Lee YH, Lim KM, Chung SM, Bae ON, Kim H, Lee CR, Park JD and Chung JH. Inorganic arsenite potentiates vasoconstriction through calcium sensitization in vascular smooth muscle. Environ Health Perspect 2005; 113: 1330-1335 

    상세보기

50. Lee TC, Tanaka N, Lamb PW, Gilmer TM and Barrett JC. Induction of gene amplification by arsenic. Science 1988; 241: 79-81 

    상세보기

51. Lewis DR, Southwick JW, Ouellet-Hellstrom R, Rench J and Calderon RL. Drinking water arsenic in Utah: A cohort mortality study. Environ Health Perspect 1999; 107: 359-365 

    상세보기

52. Lin S, Shi Q, Nix FB, Styblo M, Beck MA, Herbin-Davis KM, Hall LL, Simeonsson JB and Thomas DJ. A novel S-adenosyl-L-methionine:arsenic (III) methyltransferase from rat liver cytosol. J Biol Chem 2002; 277: 10795-10803 

    상세보기

53. Liu SX, Athar M, Lippai I, Waldren C and Hei TK. Induction of oxyradicals by arsenic: implication for mechanism of genotoxicity. Proc Natl Acad Sci U S A 2001; 98: 1643-1648 

    상세보기

54. Liu, Z, Shen J, Carbrey JM, Mukhopadhyay R, Agre P and Rosen BP. Arsenite transport by mammalian aquaglyceroporins AQP7 and AQP9. Proc Natl Acad Sci U S A 2002; 99: 6053-6058: 513-7 

    상세보기

55. Loffredo CA, Aposhian HV, Cebrian ME, Yamauchi H and Silbergeld EK. Variability in human metabolism of arsenic. Environ Res 2003; 92: 85-91 

    상세보기

56. Mandal BK, Ogra Y, Anzai K and Suzuki KT. Speciation of arsenic in biological samples. Toxicol Appl Pharmacol 2004; 198: 307-318 

    상세보기

57. Marnell LL, Garcia-Vargas GG, Chowdhury UK, Zakharyan RA, Walsh B, Avram MD, Kopplin MJ, Cebrian ME, Silbergeld EK and Aposhian HV. Polymorphisms in the human monomethylarsonic acid (MMA V) reductase/ hGSTO1 gene and changes in urinary arsenic profiles. Chem Res Toxicol 2003; 16: 1507-15132 

    상세보기

58. Mass MJ, Tennant A, Roop BC, Cullen WR, Styblo M, Thomas DJ and Kligerman AD. Methylated trivalent arsenic species are genotoxic. Chem Res Toxicol 2001; 14: 355-361 

    상세보기

59. Mazumder DN. Effect of chronic intake of arsenic-contaminated water on liver. Toxicol Appl Pharmacol 2005; 206: 169-175 

    상세보기

60. Mead MN. Arsenic: in search of an antidote to a global poison. Environ Health Perspect 2005; 113: A378-A386 

    상세보기

61. Milton AH and Rahman M. Respiratory effects and arsenic contaminated well water in Bangladesh. Int J Environ Health Res 2002; 12: 175-179 

    상세보기

62. Milton AH, Smith W, Rahman B, Hasan Z, Kulsum U, Dear K, Rakibuddin M and Ali A. Chronic arsenic exposure and adverse pregnancy outcomes in bangladesh. Epidemiology 2005; 16: 82-86？ 

    상세보기

63. Nemeti B and Gregus Z. Mitochondria work as reactors in reducing arsenate to arsenite. Toxicol Appl Pharmacol 2002; 182: 208-218 

    상세보기

64. Nesnow S, Roop BC, Lambert G, Kadiiska M, Mason RP, Cullen WR and Mass MJ. DNA damage induced by methylated trivalent arsenicals is mediated by reactive oxygen species. Chem Res Toxicol 2002; 15: 1627-1634 

    상세보기

65. Olguin A, Jauge P, Cebrian M and Albores A. Arsenic levels in blood, urine, hair and nails from a chronically exposed human population. Proc West Pharmacol Soc 1983; 26: 175-177 

66. Oremland RS and Stolz JF. The ecology of arsenic. Science 2003; 300: 939-944 

    상세보기

67. Petrick JS, Ayala-Fierro F, Cullen WR, Carter DE and Vasken Aposhian H. Monomethylarsonous acid (MMA(III)) is more toxic than arsenite in Chang human hepatocytes. Toxicol Appl Pharmacol 2000; 163: 203-207 

    상세보기

68. Petrick JS, Jagadish B, Mash EA and Aposhian HV. Monomethylarsonous acid (MMA (III)) and arsenite: LD (50) in hamsters and in vitro inhibition of pyruvate dehydrogenase. Chem Res Toxicol 2001; 14: 651-656 

    상세보기

69. Pi J, Horiguchi S, Sun Y, Nikaido M, Shimojo N, Hayashi T, Yamauchi H, Itoh K, Yamamoto M, Sun G, Waalkes MP and Kumagai Y. A potential mechanism for the impairment of nitric oxide formation caused by prolonged oral exposure to arsenate in rabbits. Free Radic Biol Med 2003; 35: 102-113 

    상세보기

70. Pi J, Kumagai Y, Sun G, Yamauchi H, Yoshida T, Iso H, Endo A, Yu L, Yuki K, Miyauchi T and Shimojo N. Decreased serum concentrations of nitric oxide metabolites among Chinese in an endemic area of chronic arsenic poisoning in inner Mongolia. Free Radic Biol Med 2000; 28: 1137-1142 

    상세보기

71. Pott WA, Benjamin SA and Yang RS. Pharmacokinetics, metabolism, and carcinogenicity of arsenic. Rev Environ Contam Toxicol 2001; 169: 165-214 

    상세보기

72. Radabaugh TR and Aposhian HV. Enzymatic reduction of arsenic compounds in mammalian systems: reduction of arsenate to arsenite by human liver arsenate reductase. Chem Res Toxicol 2000; 13: 26-30 

    상세보기

73. Rahman M, Tondel M, Ahmad SA and Axelson O. Diabetes mellitus associated with arsenic exposure in Bangladesh. Am J Epidemiol 1998; 148: 198-203 

    상세보기

74. Rahman M, Tondel M, Chowdhury IA and Axelson O. Relations between exposure to arsenic, skin lesions, and glucosuria. Occup Environ Med 1999; 56: 277-281 

    상세보기

75. Ratnaike RN. Acute and chronic arsenic toxicity. Postgrad Med J 203; 79: 391-396 

    상세보기

76. Rodriguez VM, Jimenez-Capdeville ME and Giordano M. The effects of arsenic exposure on the nervous system. Toxicol Lett 2003; 145: 1-18 

    상세보기

77. Rossman TG. Mechanism of arsenic carcinogenesis: an integrated approach. Mutat Res 2003; 533: 37-65 

    상세보기

78. Sakurai T, Qu W, Sakurai MH and Waalkes MP. A major human arsenic metabolite, dimethylarsinic acid, requires reduced glutathione to induce apoptosis. Chem Res Toxicol 2002; 15: 629-637-790 

    상세보기

79. Sampayo-Reyes A, Zakharyan RA, Healy SM and Aposhian HV. Monomethylarsonic acid reductase and monomethylarsonous acid in hamster tissue. Chem Res Toxicol 2000; 13: 1181-1186 

    상세보기

80. Schwartz RA. Arsenic and the skin. Int J Dermatol 1997; 36: 241-250 

    상세보기

81. Shi H, Shi X and Liu KJ. Oxidative mechanism of arsenic toxicity and carcinogenesis. Mol Cell Biochem 2004; 255: 67-78 

    상세보기

82. Shiobara Y, Ogra Y and Suzuki KT. Animal species difference in the uptake of dimethylarsinous acid (DMA (III)) by red blood cells. Chem Res Toxicol 2001; 14: 1446-1452 

    상세보기

83. Simeonova PP, Hulderman T, Harki D and Luster MI. Arsenic exposure accelerates atherogenesis in apolipoprotein E (-/-) mice. Environ Health Perspect 2003; 111: 1744-1748 

    상세보기

84. Simeonova PP and Luster MI. Arsenic and atherosclerosis. Toxicol Appl Pharmacol 2004; 198: 444-449 

    상세보기

85. Smedley PL a K, DG. A review of the source, behaviour and distribution of arsenic in natural waters. Appl Geochem 2002; 17: 517-568 

    상세보기

86. Smith AH, Goycolea M, Haque R and Biggs ML. Marked increase in bladder and lung cancer mortality in a region of Northern Chile due to arsenic in drinking water. Am J Epidemiol 1998; 147: 660-669 

    상세보기

87. Smith KR, Klei LR and Barchowsky A. Arsenite stimulates plasma membrane NADPH oxidase in vascular endothelial cells. Am J Physiol Lung Cell Mol Physiol 2001; 280: L442-L449 

    상세보기

88. Styblo M, Del Razo LM, Vega L, Germolec DR, LeCluyse EL, Hamilton GA, Reed W, Wang C, Cullen WR and Thomas DJ. Comparative toxicity of trivalent and pentavalent inorganic and methylated arsenicals in rat and human cells. Arch Toxicol 2000; 74: 289-299 

    상세보기

89. Styblo M, Drobna Z, Jaspers I, Lin S and Thomas DJ. The role of biomethylation in toxicity and carcinogenicity of arsenic: a research update. Environ Health Perspect 110 Suppl 2002; 5: 767-771 

90. Suzuki KT, Tomita T, Ogra Y and Ohmichi M. Glutathioneconjugated arsenics in the potential hepato-enteric circulation in rats. Chem Res Toxicol 2001; 14: 1604-1611 

    상세보기

91. Thomas DJ, Waters SB and Styblo M. Elucidating the pathway for arsenic methylation. Toxicol Appl Pharmacol 2004; 198: 319-326 

    상세보기

92. Tsai SH, Liang YC, Chen L, Ho FM, Hsieh MS and Lin JK. Arsenite stimulates cyclooxygenase-2 expression through activating IkappaB kinase and nuclear factor kappaB in primary and ECV304 endothelial cells. J Cell Biochem 2002; 84: 750-758 

    상세보기

93. Tseng CH. An overview on peripheral vascular disease in blackfoot disease-hyperendemic villages in Taiwan. Angiology 2002; 53: 529-537 

    상세보기

94. Tseng CH, Chong CK, Chen CJ and Tai TY. Dose-response relationship between peripheral vascular disease and ingested inorganic arsenic among residents in blackfoot disease endemic villages in Taiwan. Atherosclerosis 1996; 120: 125-133 

    상세보기

95. Tseng CH, Chong CK, Tseng CP, Hsueh YM, Chiou HY, Tseng CC and Chen CJ. Long-term arsenic exposure and ischemic heart disease in arseniasis-hyperendemic villages in Taiwan. Toxicol Lett 2003; 137: 15-21 

    상세보기

96. Tsou TC, Tsai FY, Wu MC and Chang LW. The protective role of NF-kappaB and AP-1 in arsenite-induced apoptosis in aortic endothelial cells. Toxicol Appl Pharmacol 2003; 191: 177-187 

    상세보기

97. Tsou TC, Yeh SC, Tsai FY and Chang LW. The protective role of intracellular GSH status in the arsenite-induced vascular endothelial dysfunction. Chem Res Toxicol 2004; 17: 208-217 

    상세보기

98. Tsuda T, Babazono A, Yamamoto E, Kurumatani N, Mino Y, Ogawa T, Kishi Y and Aoyama H. Ingested arsenic and internal cancer: a historical cohort study followed for 33 years. Am J Epidemiol 2005; 141: 198-209 

99. Vahter M. Mechanisms of arsenic biotransformation. Toxicology 2002; 181-182, 211-217 

100. Vahter M and Marafante E. Intracellular interaction and metabolic fate of arsenite and arsenate in mice and rabbits. Chem Biol Interact 1983; 47: 29-44 

     상세보기

101. Valenzuela OL, Borja-Aburto VH, Garcia-Vargas GG, Cruz-Gonzalez MB, Garcia-Montalvo EA, Calderon-Aranda ES and Del Razo LM. Urinary trivalent methylated arsenic species in a population chronically exposed to inorganic arsenic. Environ Health Perspect 2005; 113: 250-254 

     상세보기

102. Vasken Aposhian H, Zakharyan RA, Avram MD, Sampayo-Reyes A and Wollenberg ML. A review of the enzymology of arsenic metabolism and a new potential role of hydrogen peroxide in the detoxication of the trivalent arsenic species. Toxicol Appl Pharmacol 2004; 198: 327-335 

     상세보기

103. Waalkes MP, Ward JM, Liu J and Diwan BA. Transplacental carcinogenicity of inorganic arsenic in the drinking water: induction of hepatic, ovarian, pulmonary, and adrenal tumors in mice. Toxicol Appl Pharmacol 2003; 186: 7-17 

104. Wang CH, Jeng JS, Yip PK, Chen CL, Hsu LI, Hsueh YM, Chiou HY, Wu MM and Chen CJ. Biological gradient between long-term arsenic exposure and carotid atherosclerosis. Circulation 2002; 105: 1804-1809 

     상세보기

105. Wanibuchi H, Salim EI, Kinoshita A, Shen J, Wei M, Morimura K, Yoshida K, Kuroda K, Endo G and Fukushima, S. Understanding arsenic carcinogenicity by the use of animal models. Toxicol Appl Pharmacol 2004; 198: 366-376 

     상세보기

106. Watanabe C, Kawata A, Sudo N, Sekiyama M, Inaoka T, Bae M and Ohtsuka R. Water intake in an Asian population living in arsenic-contaminated area. Toxicol Appl Pharmacol 2004; 198: 272-282 

     상세보기

107. Wildfang E, Radabaugh TR and Vasken Aposhian H. Enzymatic methylation of arsenic compounds. IX. Liver arsenite methyltransferase and arsenate reductase activities in primates. Toxicology 2001; 168: 213-221 

     상세보기

108. Wu MM, Kuo TL, Hwang YH and Chen CJ. Dose-response relation between arsenic concentration in well water and mortality from cancers and vascular diseases. Am J Epidemiol 1989; 130: 1123-1132 

     상세보기

109. Xia Y and Liu J. An overview on chronic arsenism via drinking water in PR China. Toxicology 2004; 198: 25-29 

     상세보기

110. Yeh JY, Cheng LC, Ou BR, Whanger DP and Chang LW. Differential influences of various arsenic compounds on glutathione redox status and antioxidative enzymes in porcine endothelial cells. Cell Mol Life Sci 2002; 59: 1972-1982 

     상세보기

111. Yoshida T, Shimamura T, Kitagawa H and Shigeta S. The enhancement of the proliferative response of peripheral blood lymphocytes of workers in semiconductor plant. Ind Health 1987; 25: 29-33 

     상세보기

112. Yoshida T, Yamauchi H and Fan Sun G. Chronic health effects in people exposed to arsenic via the drinking water: dose-response relationships in review. Toxicol Appl Pharmacol 2004; 198: 243-2521 

     상세보기

113. Yu HS, Lee CH and Chen GS. Peripheral vascular diseases resulting from chronic arsenical poisoning. J Dermatol 2002; 29: 123-130 

     상세보기

114. Zakharyan RA and Aposhian HV. Arsenite methylation by methylvitamin B12 and glutathione does not require an enzyme. Toxicol Appl Pharmacol 1999; 154: 287-291 

     상세보기

115. Zelikoff JT, Bertin JE, Burbacher TM, Hunter ES, Miller RK, Silbergeld EK, Tabacova S and Rogers JM. Health risks associated with prenatal metal exposure. Fundam Appl Toxicol 1995; 25: 161-170 

     상세보기

저자의 다른 논문 :

배옥남 (6) 이무열 (8) 정승민 (8) 정진호 (53)